Sai Life Sciences has developed an integrated cell permeability platform to support drug discovery through automation and scalable high-throughput screening. […]
Sai’s new production block now open for business!
26 Jun 2019
The brand-new API and Intermediate manufacturing facility (Block #8) at Sai Life Sciences is the company’s largest block in terms of volume and size. It marks a 70% increase in reactor volume taking the combined capacity past 400 KL. The project was completed in an accelerated time-frame of 15 months and had the distinction of clocking 0.5 million manhours of project execution without a single lost time incident!
In addition to the increased volumetric capacity, Block #8 provides the flexibility to handle low and high volumes in a single block with 32 reactors (16 production trains) of sizes ranging from 1 KL to 10 KL. It has next generation automation, advanced containment systems, a separate storage area for staging of raw material and intermediates, an increased ratio of filter dryers to reactors ratio, a dedicated vacuum system for every two reactors, and a 5 KL cryo reactor.
Related News
Sai Life Sciences and AstraZeneca have published a study titled “ReactIR Monitoring of Turbo-Hauser Base Formation Enables a Robust Iodination […]
21 May 2026
As drug discovery programs increasingly demand faster optimization cycles and access to broader chemical space, advanced chemistry approaches are moving […]